⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL514472 | 1.00 | — | — | |
| SCHEMBL9539518 | 0.83 | KDM4E (0.41) | — | |
| SCHEMBL8186521 | 0.81 | KDM4E (0.36) | — | |
| SCHEMBL8186529 | 0.81 | KDM4E (0.36) | — | |
| SCHEMBL6122909 | 0.80 | — | — | |
| SCHEMBL3990273 | 0.79 | — | — | |
| SCHEMBL4039881 | 0.79 | — | — | |
| SCHEMBL3990272 | 0.79 | — | — | |
| SCHEMBL4599093 | 0.77 | NFKB1 (0.34) | — | |
| SCHEMBL4599052 | 0.77 | NFKB1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109655540-B | Method for analyzing related substances of salmon calcitonin nasal spray | 银谷制药有限责任公司 | 2022-08-30 | — | — | CN | claimed |
| US-9403778-B2 | Agents that prevent or repair skin damage | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2016-08-02 | — | — | US | claimed |
| WO-2015003095-A1 | SUNLESS TANNING COMPOUNDS AND COMPOSITIONS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2015-01-08 | — | — | WO | claimed |
| US-20140350036-A1 | AGENTS THAT PREVENT OR REPAIR SKIN DAMAGE | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2014-11-27 | — | — | US | claimed |
| EP-2802573-A1 | AGENTS THAT PREVENT OR REPAIR SKIN DAMAGE | Regents of the University of Minnesota (US) | 2014-11-19 | — | — | EP | claimed |
| WO-2013106728-A1 | AGENTS THAT PREVENT OR REPAIR SKIN DAMAGE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2013-07-18 | — | — | WO | claimed |
| US-7585846-B2 | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof | UNIVERSITY OF ROCHESTER (US) | 2009-09-08 | — | — | US | claimed |
| CN-111569086-B | Methylene carbamate linkers for use with target-drug conjugates | 西雅图基因公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-111558049-B | Methylene carbamate linkers for use with target-drug conjugates | 西雅图基因公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-109655540-B | Method for analyzing related substances of salmon calcitonin nasal spray | 银谷制药有限责任公司 | 2022-08-30 | — | — | CN | disclosed |
| US-10758498-B2 | Method of decreasing protein-aldehyde adducts by administering a mixed disulfide of n-acetylcysteine and propyl mercaptan, propenyl mercaptan, or allyl mercaptan | SOCTRONICS TECHNOLOGIES PRIVATE LIMITED (IN) | 2020-09-01 | — | — | US | disclosed |
| US-20200140460-A1 | ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS | VYOME BIOSCIENCES PVT. LTD. (IN) | 2020-05-07 | — | — | US | disclosed |
| US-10570152-B2 | Antibacterial therapeutics and prophylactics | VYOME THERAPEUTICS LIMITED (IN) | 2020-02-25 | — | — | US | disclosed |
| US-20030119909-A1 | Stabilized medicament containing cysteinyl derivatives | STANISLAUS, FRITZ (DE) | 2003-06-26 | — | — | US | disclosed |
| US-20020037855-A1 | Stabilized medicament containing cysteinyl derivatives | STANISLAUS FRITZ (DE) | 2002-03-28 | — | — | US | disclosed |
| EP-0850924-B1 | Aromatic diselenides and selenosulphides for use as antioxidant agents | OXIS ISLE OF MAN LTD (GB) | 2001-03-14 | — | — | EP | disclosed |
| US-6040328-A | ANTIOXIDANT AGENTS HAVING CYTOPROTECTING ACTIVITY, AND WATER SOLUBLE | OXIS INTERNATIONAL S.A. (US) | 2000-03-21 | — | — | US | disclosed |
| US-5973009-A | ANTIOXIDANT AND CYTOPROTECTING ACTIVITY | OXIS INTERNATIONAL S.A. (US) | 1999-10-26 | — | — | US | disclosed |
| EP-0850924-A1 | Aromatic diselenides and selenosulphides for use as antioxidant agents | OXIS Isle of Man, Limited (GB) | 1998-07-01 | — | — | EP | disclosed |
| US-5066716-A | Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1991-11-19 | — | — | US | disclosed |